Pancratistatin

From WikiMD's WELLNESSPEDIA

Pancratistatin is a natural compound that is derived from the Amaryllidaceae family of plants, specifically the Narcissus genus. It is a potent anti-cancer agent that has been the subject of extensive research due to its potential therapeutic applications.

History[edit]

Pancratistatin was first isolated in 1985 from the bulbs of the Narcissus plant. The compound was named after the plant species from which it was derived, Pancratium littorale, a member of the Amaryllidaceae family.

Structure and Properties[edit]

Pancratistatin is a polycyclic alkaloid with a complex structure. It is composed of a bicyclic ring system with a six-membered ring fused to a five-membered ring, and a three-membered ring attached to the five-membered ring. The compound also contains several hydroxyl groups and a methoxy group.

Biological Activity[edit]

Pancratistatin has been found to have potent anti-cancer activity. It induces apoptosis, or programmed cell death, in various types of cancer cells, including leukemia, lung, breast, and prostate cancer cells. The compound acts by disrupting the mitochondrial membrane potential, leading to the release of cytochrome c and activation of the apoptotic pathway.

Therapeutic Potential[edit]

Due to its potent anti-cancer activity, pancratistatin has significant potential as a therapeutic agent. Research is ongoing to develop methods for the synthesis of pancratistatin and its analogs, and to investigate their potential use in cancer treatment.

See Also[edit]

This article is a stub related to chemistry. You can help WikiMD by expanding it!



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.